Figure 3
From: Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients
Longitudinal profile of SARS-CoV-2 antibodies in asymptomatic and mild COVID19 patients. (A) IgM vs. IgG-S, (B) IgG-S vs. IgG-N antibodies. Data are fitted by a quadratic polynomial regression model, and presented for asymptomatic patients (N = 22, blue), the mild cohort (N = 96, black) and for non-inflammatory cluster (N = 40), and the inflammatory cluster (N = 56). For full details, see also Supplementary Figs. 2–4. AS asymptomatic, I mild inflammatory related symptoms, N-I mild non-inflammatory related symptoms, MILD all mild symptoms.
